|
Variables
|
Event
|
Censored
|
CHR, 95% CI
|
AHR and 95% CI
|
p-value
|
|---|
|
Diarrhoea
|
|
Yes
|
31
|
173
|
1.66 (0.8–2.69)
|
1.37 (0.79–2.4)
|
0.254
|
|
No
|
35
|
288
|
1
|
1
| |
|
Heart failure
|
|
Yes
|
65
|
458
|
1.39 (0.63–3.06)
|
2.35 (0.91–6.02)
|
0.07
|
|
No
|
58
|
427
|
1
|
1
| |
|
Hiv/Aids
|
|
Reactive
|
6
|
12
|
6.84 (0.43–19.2)
|
1.5 (0.45–4.97)
|
0.507
|
|
Non-react
|
51
|
281
|
2.96 (0.46–6.02)
|
1.6 (0 .75–3.4)
|
0.215
|
|
Unknown
|
9
|
168
|
1
|
1
| |
|
Pneumonia
|
|
Yes
|
9
|
65
|
0.93 (0.46–1.88)
|
1.1 (0.5–2.45)
|
0.8
|
|
No
|
57
|
396
|
1
|
1
| |
|
Folic acid
|
|
Yes
|
36
|
346
|
1
|
1
|
0.525
|
|
No
|
30
|
114
|
2.4 (1.48–3.9)
|
1.2 (0.67–2.16)
| |
|
Anemia(< 11 mg/dl)
|
|
Yes
|
49
|
221
|
2.57 (1.46–4.53)
|
2.37 (1.24–4.51)
|
0.023*
|
|
No
|
16
|
226
|
1
|
1
| |
|
Shock
|
|
Yes
|
34
|
9
|
19.02 (11.65–31)
|
7.95 (3.72–16.7)
|
< 0.001*
|
|
No
|
32
|
449
|
1
|
1
| |
|
NGT feeding
|
|
Yes
|
44
|
154
|
3.35 (2.0–5.61)
|
1.56 (0.7–2.04)
|
0.1
|
|
No
|
22
|
307
|
1
|
1
| |
|
Routine Antibiotics
|
|
Yes
|
24
|
272
|
1
|
1
|
0.007*
|
|
No
|
42
|
189
|
2.46 (1.49–4.07)
|
2.35 (1.25–4.4)
| |
|
Iv fluid
|
|
Yes
|
48
|
77
|
9.61 (5.58–16.5)
|
3.21 (1.75–5.88)
|
< 0.001*
|
|
No
|
18
|
384
|
1
|
1
| |
|
Blood transfusion
|
|
Yes
|
27
|
31
|
6.36 (3.8–10.4)
|
1.9 (0.93–3.88)
|
0.077
|
|
No
|
39
|
430
|
1
|
1
| |
|
Intake of F75
|
|
Yes
|
51
|
377
|
1
|
1
|
< 0.001*
|
|
No
|
15
|
84
|
1.70 (0.95–3.04)
|
6.58 (2.9–14.68)
| |
|
Intake F100
|
|
Yes
|
24
|
315
|
1
|
1
|
< 0.001*
|
|
No
|
42
|
146
|
5.27 (3.15–8.79)
|
3 (1.67–5.41)
| |
|
Deworming
|
|
Yes
|
5
|
54
|
1
|
1
|
0.45
|
|
No
|
61
|
407
|
1.8 (0.9–9.2)
|
1.61 (0.46–5.64)
| |
|
Pulse
|
|
Normal
|
20
|
243
|
1
|
1
|
0.37
|
|
Altered
|
46
|
211
|
2.34 (0.39–3.97)
|
2.39 (0.24–4.61)
| |
- *Significant predictors in the multivariable analysis
- HIV/AIDS Human Immune-Virus /Acquired Immune Deficiency Syndrome
- NGT Naso Gastric Therapy